Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Cash from Operations (2018 - 2025)

TELA Bio (TELA) has 8 years of Cash from Operations data on record, last reported at 5719000.0 in Q3 2025.

  • For Q3 2025, Cash from Operations rose 36.34% year-over-year to 5719000.0; the TTM value through Sep 2025 reached 30880000.0, up 31.55%, while the annual FY2024 figure was 41595000.0, 1.81% down from the prior year.
  • Cash from Operations reached 5719000.0 in Q3 2025 per TELA's latest filing, up from 7905000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 5629000.0 in Q2 2021 and bottomed at 14384000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 9314789.47, with a median of 9588000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: plummeted 107.6% in 2022, then surged 36.34% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 9588000.0 in 2021, then fell by 14.55% to 10983000.0 in 2022, then decreased by 0.62% to 11051000.0 in 2023, then skyrocketed by 31.85% to 7531000.0 in 2024, then increased by 24.06% to 5719000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 5719000.0 in Q3 2025, 7905000.0 in Q2 2025, and 9725000.0 in Q1 2025.